Cargando…

Intramuscular pyrethroid with organophosphorus (cypermethrine 3% + quinolphos 20%) mixed poisoning, its clinical presentation and management

Organophosphorus compounds are absorbed by any route including intramuscular injection. Pyrethroid compounds are less toxic for human but in combination with organophosphates, its toxic effect potentiates due to inhibition of its metabolism. In this case report, a 40-year-old female patient presente...

Descripción completa

Detalles Bibliográficos
Autores principales: Nizami, Mohammad Firoz, Sharma, Chandra B., Singh, Bhoopendra, Guria, Rishi T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380745/
https://www.ncbi.nlm.nih.gov/pubmed/32754535
http://dx.doi.org/10.4103/jfmpc.jfmpc_16_20
_version_ 1783562900993998848
author Nizami, Mohammad Firoz
Sharma, Chandra B.
Singh, Bhoopendra
Guria, Rishi T.
author_facet Nizami, Mohammad Firoz
Sharma, Chandra B.
Singh, Bhoopendra
Guria, Rishi T.
author_sort Nizami, Mohammad Firoz
collection PubMed
description Organophosphorus compounds are absorbed by any route including intramuscular injection. Pyrethroid compounds are less toxic for human but in combination with organophosphates, its toxic effect potentiates due to inhibition of its metabolism. In this case report, a 40-year-old female patient presented with acute onset of pain abdomen, recurrent vomiting, and excessive salivation followed by altered mental status, on evaluation her clinical findings were suggestive of organophosphorus poisoning. Her treatment was started with injection atropine, anti-emetics, and adequate parenteral rehydration. After regaining consciousness, the patient confessed that she had taken herself intramuscular injection of pesticide which contained 3% cypermethrine plus 20% quinolphos. It was further confirmed by a very low level of plasma cholinesterase level. Intramuscular injection acted as a depot that leads to prolong intoxication and in the due course of illness, she also developed delayed onset intermediate syndrome that was managed appropriately.
format Online
Article
Text
id pubmed-7380745
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-73807452020-08-03 Intramuscular pyrethroid with organophosphorus (cypermethrine 3% + quinolphos 20%) mixed poisoning, its clinical presentation and management Nizami, Mohammad Firoz Sharma, Chandra B. Singh, Bhoopendra Guria, Rishi T. J Family Med Prim Care Case Report Organophosphorus compounds are absorbed by any route including intramuscular injection. Pyrethroid compounds are less toxic for human but in combination with organophosphates, its toxic effect potentiates due to inhibition of its metabolism. In this case report, a 40-year-old female patient presented with acute onset of pain abdomen, recurrent vomiting, and excessive salivation followed by altered mental status, on evaluation her clinical findings were suggestive of organophosphorus poisoning. Her treatment was started with injection atropine, anti-emetics, and adequate parenteral rehydration. After regaining consciousness, the patient confessed that she had taken herself intramuscular injection of pesticide which contained 3% cypermethrine plus 20% quinolphos. It was further confirmed by a very low level of plasma cholinesterase level. Intramuscular injection acted as a depot that leads to prolong intoxication and in the due course of illness, she also developed delayed onset intermediate syndrome that was managed appropriately. Wolters Kluwer - Medknow 2020-05-31 /pmc/articles/PMC7380745/ /pubmed/32754535 http://dx.doi.org/10.4103/jfmpc.jfmpc_16_20 Text en Copyright: © 2020 Journal of Family Medicine and Primary Care http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Case Report
Nizami, Mohammad Firoz
Sharma, Chandra B.
Singh, Bhoopendra
Guria, Rishi T.
Intramuscular pyrethroid with organophosphorus (cypermethrine 3% + quinolphos 20%) mixed poisoning, its clinical presentation and management
title Intramuscular pyrethroid with organophosphorus (cypermethrine 3% + quinolphos 20%) mixed poisoning, its clinical presentation and management
title_full Intramuscular pyrethroid with organophosphorus (cypermethrine 3% + quinolphos 20%) mixed poisoning, its clinical presentation and management
title_fullStr Intramuscular pyrethroid with organophosphorus (cypermethrine 3% + quinolphos 20%) mixed poisoning, its clinical presentation and management
title_full_unstemmed Intramuscular pyrethroid with organophosphorus (cypermethrine 3% + quinolphos 20%) mixed poisoning, its clinical presentation and management
title_short Intramuscular pyrethroid with organophosphorus (cypermethrine 3% + quinolphos 20%) mixed poisoning, its clinical presentation and management
title_sort intramuscular pyrethroid with organophosphorus (cypermethrine 3% + quinolphos 20%) mixed poisoning, its clinical presentation and management
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7380745/
https://www.ncbi.nlm.nih.gov/pubmed/32754535
http://dx.doi.org/10.4103/jfmpc.jfmpc_16_20
work_keys_str_mv AT nizamimohammadfiroz intramuscularpyrethroidwithorganophosphoruscypermethrine3quinolphos20mixedpoisoningitsclinicalpresentationandmanagement
AT sharmachandrab intramuscularpyrethroidwithorganophosphoruscypermethrine3quinolphos20mixedpoisoningitsclinicalpresentationandmanagement
AT singhbhoopendra intramuscularpyrethroidwithorganophosphoruscypermethrine3quinolphos20mixedpoisoningitsclinicalpresentationandmanagement
AT guriarishit intramuscularpyrethroidwithorganophosphoruscypermethrine3quinolphos20mixedpoisoningitsclinicalpresentationandmanagement